CRISPR Therapeutics (CRSP) Earnings Report - Discounting Cash Flows
CRISPR Therapeutics AG
CRSP (NASDAQ)

* (except for per share items) of USD
Period Ending: 2025
08-04
2025
05-06
2025
02-19
2024
11-04
2024
08-05
2024
05-08
2024
02-21
2023
11-06
2023
08-07
2023
05-08
2023
02-21
2022
11-01
2022
08-08
2022
05-09
2022
02-15
2021
11-03
2021
07-29
2021
04-27
2021
02-16
2020
10-28
2020
07-27
2020
04-28
2020
02-12
2019
10-28
2019
07-29
2019
04-29
2019
02-25
2018
11-07
2018
08-07
2018
05-08
2018
03-08
2017
11-08
2017
08-10
2017
05-11
2017
03-10
2016
11-22
2016
06-30
2016
03-31
2015
12-31
2015
09-30
Actual EPS - - - - -1.49 -1.43 1.10 -1.41 -0.98 -0.67 -1.41 -2.24 -2.40 -2.32 -1.84 -1.67 9.44 -1.51 -1.50 -1.32 -1.30 -1.15 0.51 2.40 -1.01 -0.93 -0.92 -1.07 -0.82 -0.62 0.00 -0.62 -0.56 -0.54 -0.40 -2.77 -0.43 -0.29 -0.42 -0.22
Estimated EPS - - - -1.33 -1.37 -1.63 -0.07 -1.98 -2.18 -1.67 -2.32 -2.30 -2.23 -1.91 -1.74 -1.69 3.52 -1.45 -1.23 -1.17 -0.92 -1.09 -0.63 -0.95 -0.81 -0.88 -0.83 -0.74 -0.65 -0.67 -0.71 -0.60 -0.62 -0.51 -0.38 -0.72 - - - -
Actual Revenue - - - - 0.52 0.50 200 - 70.0 100 0.01 0.09 0.16 0.18 12.3 0.33 900 0.20 0.19 0.15 0.04 0.16 77.0 212 0.32 0.33 0.12 0.56 1.09 1.36 32.3 2.39 3.58 2.70 2.34 1.55 0.80 0.48 0.25 -
Estimated Revenue - - - 6.81 16.6 3.54 28.1 7.96 1.71 1.71 23.0 - - 0.14 2.14 0.83 846 1.21 2.50 0.13 0.03 0.14 95.1 83.9 0.28 0.31 0.10 0.39 0.84 1.47 - 2.31 3.97 3.05 0.81 2.58 - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us